Skip to main content
Premium Trial:

Request an Annual Quote

LifeLabs Offering NanoString's Breast Cancer MDx in Canada

NEW YORK( GenomeWeb) – LifeLabs Medical Laboratory Services today said it is offering NanoString's Prosigna Breast Cancer Prognostic Gene Signature Assay in Canada. 

LifeLabs said it is the first clinical lab in the country to offer the test, which is approved by Health Canada and cleared by the US Food and Drug Administration

Prosigna is a gene expression-based test that evaluates the genetic profile of cells found in breast cancer tissue to assess the 10-year risk of recurrence of cancer in post-menopausal, hormone-receptor positive women with early-stage breast cancer. LifeLabs said Prosigna is the only molecular test in its class to be approved by Canadian regulators. 

"This test can help physicians determine whether breast cancer patients will benefit from chemotherapy treatment or whether other treatment options are more appropriate," LifeLabs CEO Sue Paish said in a statement. "By providing this molecular test inCanada, physicians can make quicker treatment decisions by having faster access to important clinical information."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.